UBS Maintains Buy on Teradyne, Lowers Price Target to $430
UBS analyst Timothy Arcuri maintains Teradyne (NASDAQ:TER) with a Buy and lowers the price target from $485 to $430.
Share
Why It Matters
A big bank analyst still thinks Teradyne is a good company to own. But they lowered how much they think the stock is worth right now.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.